Bio-Techne Q1 FY26: where the revenue came from and where it went
The whole income statement of Bio-Techne for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2025
- Reported
- Nov 5, 2025
Revenue$0.29B
−1% year over year
Gross profit$0.19B
66% margin
Operating profit$0.05B
17% margin
Net profit$0.04B
13% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.29 | 100% | −1% |
| Consumables | 0.23 | 81% | +0% |
| Services | 0.03 | 9% | +0% |
| Instruments | 0.02 | 8% | −17% |
| Royalty | 0.01 | 2% | +12% |
| Cost of revenue | −0.10 | 34% | |
| Gross profit | 0.19 | 66% margin | +2pp |
| SG&A | −0.12 | 41% | −1pp |
| Other | −0.02 | 8% | +0pp |
| Operating profit | 0.05 | 17% margin | +3pp |
| Tax | −0.01 | ||
| Net profit | 0.04 | 13% margin | +2pp |
39 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest